Neuropeptide Y, neurokinin A and neurotensin in brain regions of Fawn Hooded 'depressed', Wistar, and Sprague Dawley rats. Effects of electroconvulsive stimuli

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 22, Issue 3, 1998, Pages 529-546

  Mathé, Aleksander A ^a   Jimenez, Patricia A ^a   Theodorsson, Elvar ^b   Stenfors, Carina ^c  

^a ST GÖRAN S HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Depression; Electroconvulsive stimuli; Fawn Hooded; Neurokinin A; Neuropeptide Y; Neurotensin; Rat brain

Indexed keywords

NEUROKININ A; NEUROPEPTIDE Y; NEUROTENSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DEPRESSION; ELECTROCONVULSIVE THERAPY; FRONTAL CORTEX; HYPOTHALAMUS; IMMUNOREACTIVITY; NONHUMAN; OCCIPITAL CORTEX; RAT;

ANIMALS; BRAIN CHEMISTRY; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; ELECTROSHOCK; IMMUNOHISTOCHEMISTRY; MALE; NEUROKININ A; NEUROPEPTIDE Y; NEUROTENSIN; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR;

EID: 0032055089     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(98)00023-2     Document Type: Article

References (72)

1. ALTEMUS, M., SMITH, M.A., DIEP, V., AULAKH, C.S. and MURPHY, D.L. (1995) Increased mRNA for corticotrophin releasing hormone in the amygdala of Fawn Hooded rats: A potential animal model of anxiety. Anxiety 1:251-257.
2. AULAKH, C.S., HILL, J.L. and MURPHY D.L. (1989) A comparison of feeding and response to serotonin agonists in three rat strains. Pharmacol. Biochem. Behav. 31:567-571.
3. AULAKH, C.S., HILL, J.L. and MURPHY, D.L. (1993) Attenuation of hypercortisolemia in Hooded rats by antidepressant drugs. Eur. J. Pharmacol. 240:85-88.
4. AULAKH, C.S., TOLLIVER, T., WOZNIAK, K.M., HILL, J.L. and MURPHY, D.L.(1994) Functional and biochemical evidence for altered serotonergic function in the Fawn-Hooded rat strain. Pharmacol. Biochem. Behav. 49:615-620.
5. AULAKH, C.S., MAZZOLA-POMIETO, P. and MURPHY, D.L. (1995) Long-term antidepressant treatments alter 5-HT2A and 5-HT2C receptor-mediated hyperthermia in Fawn-Hooded rats. Eur. J. Pharmacol. 282:65-70.
6. BEAUREGARD, M., FERRON, A.and DESCARRIES, L. (1992) Opposite effects of neurotensin on dopamine inhibition in different regions of the rat brain: an iontophoretic study. Neuroscience 47:613-619
7. BELLMANN, R. and SPERK, G. (1993) Effects of antidepressant drug treatment on levels of NPY or prepro-NPY-mRNA in the rat brain. Neurochem. Int. 22:183-187.
8. BERRETTINI, W.H., DORAN, A. R., KELSOE, J., ROY, and A. PICKAR, D. (1987) Cerebrospinal fluid neuropeptide Y in depression and schizophrenia. Neuropsychopharmacology 1:81-83.
9. BLAHA, C.D., COURY, A., FIBIGER, H.C. and PHILLIPS A.G. (1990) Effects of neurotensin on dopamine release and metabolism in the rat striatum and nucleus accumbens: cross validation using in vivo voltammetry, and microdialysis. Neuroscience 24:699-705.
10. CHENG, J.T., CHANG, C.L.and TSIA, C.L. (1992) Inhibitory effect of neuropeptide Y (NPY) on the in vitro activity of dopamine-β-hydroxylase. Neurosci. Lett. 136:36-38.
11. CHAPMAN, M.A., SEE, E. and BISSETTE, B. (1992) Neurotensin increases extracellular striatal dopamine levels in vivo. Neurochem. Int. 20:175-183.
12. COLMERS, W.F. and BLEAKMAN, D. (1994) Effects of neuropeptide Y on the electrical properties of neurons. TINS 17:375-379.
13. DE SAUZA E.B. and GRIGORIADIS, D.E. (1995) Corticotropin-releasing Factor. Physiology, Pharmacology, and Role in Central Nervous System and disorders. In: Psychopharmacology: The Fourth Generation of Progress, F.E. Bloom, D.J. Kupfer (Eds), pp. 505-517, Raven press, New York.
14. DEUTCH, A.Y. and ZAHM, D.S. (1992) The current status of neurotensin-dopamine interactions. Issues and speculations. Ann. N.Y. Acad. Science 668:232-252.
15. DEVANANT, D.P. and SACKHEIM, H.A. (1990) Electroconvulsive therapy: Efficacy, side effects and mechanisms of action. Prog. Basic Clin. Pharmacol. 3:170-210.
16. DURING, M.J., BEAN, A.J., and ROTH, R.H. (1992) Effects of CNS stimulants on the in vivo release of the colocalized transmitters, dopamine and neurotensin, from rat prefrontal cortex. Neurosci. Lett. 140:129-133.
17. FOCHTMANN, L.J. (1994) Animal studies of electroconvulsive therapy: Foundations for future research. Psychopharmacol. 30:321-444.
18. GLOWINSKI, J., and IVERSEN, L.L. (1965) Regional studies of catecholamines in the rat brain: The disposition of (3H) norepinephrine, (3H) dopamine and (3H) dopa in various regions of the brain. J. Neurochem. 13:655-669.
19. GRUBER, S. and MATHÉ, A.A. (1996) Both antipsychotic drugs and psychotomimetic compounds affect peptides in brain. Nordic J. Psychiatry 50:106.
20. HEILIG, M., WAHLESTEDT, C., EKMAN, R. and WIDERLÖV, E. (1988) Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain. Eur. J. Pharmacol. 147:465-467.
21. HEILIG, M. and WIDERLÖV, E. (1995) Neurobiology and clinical aspects of neuropeptide Y. Crit. Rev. Neurobiology 9:115-136.
22. HERTEL, P., MATHÉ, J.M., NOMIKOS, G.G., IURLO, M., MATHÉ, A.A. and SVENSSON, T.H. (1996) Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat. Behav. Brain Res. 72:103-114.
23. HULIHAN-GIBLIN, B.A., PARK, Y.D., GOLDMAN, D. and AULAKH, C.S. (1993) Analysis of the 5-HT receptor the serotonin uptake site in Fawn-Hooded rat brain. Eur. J. Pharmacol. 239:99-102.
24. JOUSISTO-HANSSON, J., STENFORS, C., THEODORSSON, E. and MATHÉ, A.A. (1994) Effect of lithium on rat brain neurotensin, corticotropin releasing factor, somatostatin and vasoactive intestinal peptide. Lithium 5:83-90.
25. KOMBIAN, S.B. and COLMERS, W.F. (1992) Neuropeptide Y selectively inhibits slow potentials in rat dorsal raphe nucleus in vitro by a presynaptic action. J. Neurosci. 12: 1086-1093.
26. LEVANT, B. and NEMEROFF, C.B. (1992) Further studies on the modulation of regional brain neurotensin concentrations by antipsychotic drugs: Focus on haloperidol and BMY 148021. J. Pharmacol. Exp. Ther. 262:348-355.
27. LINDEFORS, N., BRODIN, E., THEODORSSON-NORHEIM, E. and UNGERSTEDT, U. (1989) Amphetamine facilitates the in vivo release of neurokinin A in the nucleus accumbens of the rat. Eur. J. Pharmacol. 160:417-420.
28. MATHÉ, A.A., BERGMAN, P., APÉRIA, B. and WETTERBERG, L. (1987) Electroconvulsive therapy and plasma prostaglandin E2 metabolite in treatment of depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiat. 11:701-707.
29. MATHÉ, A.A., JOUSISTO-HANSON, J., STENFORS, C. and THEODORSSON, E. (1990a) Effect of lithium on tachykinins, calcitonin gene-related peptide, and neuropeptide Y in rat brain. J. Neurosci. Res. 26:233-237.
30. MATHÉ, A.A., STENFORS, C., BRODIN, E. and THEODORSSON, E. (1990b) Neuropeptides in brain: Effects of microwave irradiation and decapitation. Life Sci 46:287-293.
31. MATHÉ, A.A., ÅGREN, H., SRINIVASAN, G.R., THEODORSSON, E. and VAN KAMMEN, D.P. (1993) Calcitonin gene-related peptide (CGRP), endothelin (ET) and neuropeptide Y (NPY) in cerebrospinal fluid (CSF) of patients with schizophrenia and major depression. Psychopharmacology 111:B3.
32. MATHÉ, A.A., NORSTEDT-WIKNER, B., STENFORS, C. and THEODORSSON, E. (1994) Effects of lithium on neuropeptide Y, neurokinin A and substance P in brain and peripheral tissues of rat. Lithium 5:241-247.
33. MATHÉ, A.A., NOMIKOS, G.G. and SVENSSON, T.H. (1995) Effects of acute and chronic electroconvulsive treatment on interstitial concentrations of somatostatin in the rat hippocampus and striatum. Prog. Neuropsychopharmacol. Biol. Psychiatry 19:323-332.
34. MATHÉ, A.A., RUDORFER, M.V., STENFORS, C., MANJI, H.K., POTTER, W.Z. and THEODORSSON, E. (1996) Effects of electroconvulsive treatment on somatostatin, neuropeptide Y, endothelin, and neurokinin A concentrations in cerebrospinal fluid of depressed patients. Depression 3:250-256.
35. MATHÉ, A.A., GRUBER, S., JIMENEZ, P., THEODORSSON, E. and STENFORS, C. (1997) Effects of electroconvulsive stimuli and MK-801 on neuropeptide Y, neurokinin A and calcitonin gene-related peptide in rat brain. Neurochem. Res., 22:629-636.
36. MERCHANT, K.M. and DORSA, D.M. (1993) Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. Proc. Natl. Acad. Sci. 90:3447-3451.
37. MIKKELSEN, J.D., WOLDBYE, D., KRAGH, J., LARSEN, P.J. and BOLWIG, T.G. (1994) Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and the dentate gyrus. Mol. Brain Res. 23:317-322.
38. ORDWAY, G.A., STOCKMEIER, C.A., MELTZER, H.Y., OCERHOLSER, J.C., JACONETTA, S. and WIDDOWSON, P.S. (1995) Neuropeptide Y in frontal cortex is not altered in major depression. J. Neurochem. 65:1646-1650.
39. OVERSTREET, D.H., REZVANI, A. and JANOWSKY, D.S. (1992) Genetic animal models of depression and ethanol preference provide support for cholinergic and serotonergic involvement in depression and alcoholism. Biol. Psychiatry 31:919-936.
40. OVERSTREET, D. H. (1993) The flinders sensitive line rats. A genetic animal model of depression. Neurosci. Biobehav. Rev. 17:51-68.
41. RADKE, J.M., MACLENNAN, A.J., BEINFELD, M.C., BISSETTE, G., NEMEROFF, C.B., VICENT, S.R. and FIBIGER, H.C. (1989) Effects of short- and long-term haloperidol administration and neurotensin concentrations in the rat. Brain Res. 480:178-183.
42. ROWE, W., VIAU, V., MEANEY, M.J. and QUIRION, R. (1992) Central administration of neurotensin stimulates hypothalamic-pituitary-adrenal activity. Ann. N. Y. Acad. Sci. 668:365-367.
43. ROWE, W., VIAU, V., MEANEY, M.J. and QUIRION, R. (1995) Stimulation of CRH-mediated ACTH secretion by central administration of neurotensin: Evidence of the participation of the paraventricular nucleus. J. Endocrinology 7:109-117.
44. RUBINOW, D.R., DAVIS, C.L. and POST, R.M. (1995) Somatostatin in the Central Nervous System. In: Psychopharmacology: The Fourth Generation of Progress, F.E. Bloom and D.J. Kupfer, (Eds), pp. 553-562, Raven press, New York.
45. SACKEIM, H.A., DEVAN, D.P., PRUDIC, J. (1991) Stimulus intensity, seizure threshold, and seizure duration: Impact on the efficacy and safety of electroconvulsive therapy. In: The Psychiatric Clinics of North America: Electroconvulsive therapy, C.H. Kellner (Ed), 14, pp. 803-843, W.B. Saunders Company, London.
46. SHARP, T., ZETTERSTRÖM, T., LJUNGBERG, T. and UNGERSTEDT, U. (1987) A direct comparison of amphetamine-induced behaviors and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res. 401:322-330.
47. SINGH, N.A., BUSH, L.G., GIBB, J.W., and HANSSON, G.R. (1992) Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems. Brain Res. 571:260-264.
48. STENFORS, C., THEODORSSON, E. and MATHÉ, A.A. (1989) Effect of repeated electroconvulsive treatment on regional concentrations of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y, and galanin in rat brain. J. Neurosci. Res. 24:445-450.
49. STENFORS, C., THEODORSSON, E. and MATHÉ, A.A. (1992a) Brain neuropeptides: Changes by treatment with the convulsants pentylenetetrazole and bicuculline. Prog. Neuropsychopharmacol. Biol. Psychiatry 16:747-753.
50. STENFORS, C., SRINIVASAN, G.R., THEODORSSON, E. and MATHÉ, A.A. (1992b) Electroconvulsive stimuli and brain peptides: Effect of modification of seizure duration on neuropeptide Y, neurokinin A, substance P and neurotensin. Brain Res. 596:251-258.
51. STENFORS, C., MATHÉ, A.A. and THEODORSSON, E. (1994) Repeated electroconvulsive stimuli: Changes in neuropeptide Y, neurotensin and tachykinin concentrations in time. Prog. Neuropsychopharmacol. Biol. Psychiatry 18:201-209.
52. STENFORS, C., BJELLERUP, P., MATHÉ, A.A. and THEODORSSON, E. (1995a) Concurrent analysis of neuropeptides and biogenic amines in brain tissue of rats treated with electroconvulsive stimuli. Brain Res. 698:39-45.
53. STENFORS, C., MATHÉ, A.A. and THEODORSSON, E. (1995b) Chromatographic and immunochemical characterization of rat brain neuropeptide Y-like immunoreactivity (NPY-LI) following repeated electroconvulsive stimuli. J. Neurosci. Res. 41:206-212.
54. THEODORSSON-NORHEIM, E. and ROSELL, S. (1983) Characterization of human plasma neurotensin-like immunoreactivity after fat ingestion. Reg. Pept. 6:207-218.
55. THEODORSSON-NORHEIM, E., HEMSÉN, A. and LUNDBERG, J.M. (1985) Radioimmunoassay for neuropeptide Y (NPY): Chromatografic characterization of immunoreactivity in plasma and tissue extracts. Scand. J. Clin. Lab. Invest. 45:355-365.
56. THEODORSSON, E., MATHÉ, A.A. and STENFORS, C. (1990a) Brain neuropeptides: Tachykinins, neuropeptide Y, neurotensin and vasoactive intestinal polypeptide in the rat brain: modifications by ECT and indomethacin. Prog. Neuropsychopharmacol. Biol. Psychiatry 14:387-407.
57. THEODORSSON, E., STENFORS, C. and MATHÉ, A.A. (1990b) Microwave irradiation increases recovery of neuropeptides from brain tissues. Peptides 11:1191-1197.
58. TSUDA, K., TSUDA, S., GOLDSTEIN, M. and MASUYAMA, Y. (1990) Effects of neuropeptide Y on norepinephrine release in hypothalamic slices of spontaneously hypertensive rats. Eur. J. Pharmacol. 182:175-179.
59. VAN DEN BOS, R., COOLS, A.R. and ÖGREN, S.O. (1990) Neurokinin A enhances the stimulatory effects of d-amphetamine on motor activity in the nucleus accumbens of the rat. Acta Physiol. Scand. 138:423-424.
60. WAHLESTEDT, C., BLENDY, J.A., KELLAR, K.J., HEILIG, M., WIDERLÖV, E. and EKMAN, R. (1990) Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat. Brain Res. 507:65-68.
61. WAHLESTEDT, C., KAROUM, F., JASKIW, G., WYATT, J.R., LARHAMMAR, D., EKMAN R., and REIS, D.J. (1991) Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex. Prog. Natl. Acad. Sci. 88:2078-2082.
62. WAHLESTEDT, C., PICH, E.M., KOOB, G.F., YEE, F. and HEILIG, M. (1993) Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259:528-531.
63. WAHLESTEDT, C. and HEILIG, M. (1995) Neuropeptide Y and related peptides. In: Psychopharmacology: The Fourth Generation of Progress, F.E. Bloom and D.J. Kupfer, (Eds), pp. 543-551, Raven press, New York.
64. WEISS, J.M., GOODMAN, A., LOSITO, B.G., CORRIGAN, S., CHARRY, J.M. and BAILEY, W.H. (1981) Behavioral depression produced by an uncontrollable stressor: relationship between norepinephrine, dopamine, and serotonin levels in various regions of rat brain. Brain Res. Rev. 3:167-205.
65. WIDDOWSON, P.S. and HALARIS, A.E. (1988) Increased levels of neuropeptide Y-immunoreactivity in rat brain limbic structures following antidepressant treatment. J. Neurochem. 52:77-86.
66. WIDDOWSON, P.S., ORDWAY, G.A. and HALARIS, A.E. (1992) Reduced neuropeptide Y in suicide brain. J. Neurochem. 59:69-79.
67. WIDERLÖV, E., LINDSTRÖM, L.H., WAHLESTEDT, C., and EKMAN, R. (1988) Neuropeptide Y and peptide YY as possible cerebrospinal markers for major depression and schizophrenia, respectively. J. Psychiat. Res. 22:69-79.
68. WILLNER, P. (1995) Animal models of depression: Validity and applications. In: Depression and mania: From Neurobiology to treatment. G. Gessa, W. Fratta, L. Pani, G. Serra (Eds), pp. 4919-4941, Raven Press, New York.
69. WOO, N.D., MUKHERJEE, K., and GANGULY, P.K. (1993) Norepinephrine levels in paraventricular nucleus of spontaneously hypertensive rats: role of neuropeptide Y. Amer. J. Physiol. 265:H893-H898.
70. ZACHRISSON, O., MATHÉ, A.A., STENFORS, C. and LINDEFORS, N. (1995) Limbic effects of repeated electroconvulsive stimulation on neuropeptide Y and somatostatin mRNA expression in the rat brain. Molec. Brain Res. 31:71-85.
71. 1 receptor mRNA in specific regions of the rat striatum after electroconvulsive stimuli. Eur. J. Pharmac., 319:191-195.
72. ZHENG, J., MORRISETT, R.A., ZHU, J. and HEXUM, T.D. (1995) Neuropeptide Y (18-36) modulates chromaffin cell catecholamine secretion by blocking the nicotinic receptor ion channel. J. Pharmacol. Exp. Ther. 274:891-897.